Role of 8-epi PGF(2α), 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 58, Issue 1, 1998, Pages 9-16

  Hart, C M ^a,c   Karman, R J ^a   Blackburn, T L ^a   Gupta, M P ^a   Garcia, J G N ^a   Mohler III, E R ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c OPW 425   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LIPID HYDROPEROXIDE; PROSTAGLANDIN F2 ALPHA DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ANALYSIS; ENZYME IMMUNOASSAY; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0031983418     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90124-7     Document Type: Article

References (42)

1. Cross C. E. Oxygen radicals and human disease. Ann Intern Med 1987; 107:526-545.
2. Bishop C. T., Mirza Z., Crapo J. D., Freeman B. A. Free radical damage to cultured porcine aortic endothelial cells and lung fibroblasts: modulation by culture conditions. In Vitro Cell Dev Biol 1985; 21:229-236.
3. Suttorp N., Simon M. L. Lung cell oxidant injury-enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest 1982; 70:342-350.
4. Weiss S. J., Young J., LoBuglio A. F, Slivka A., Nimeh N. F. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981; 68:714-721.
5. Shasby D. M., Iind S. E., Shasby S. S., Goldmith J. C., Hunninghake G. W. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood 1985; 65: 605-614.
6. Siflinger-Birnboim A., Bode D. C., Malik A. B. Adenosine 3′,5′-cyclic monophosphate attenuates neutrophil-mediated increase in endothelial permeability. Am J Physiol 1993; 264: H370-H375.
7. Hart C. M., Andreoli S. P., Patterson C. E., Garcia J. G. N. Oleic acid supplementation reduces oxidant-mediated dysfunction of cultured porcine pulmonary artery endothelial cells. J Cell Physiol 1993; 156:24-34.
8. Hinshaw D. B., Armstrong B. C., Burger J. M., Beals T. F., Hyslop P. A. ATP and microfilaments in cellular oxidant injury. Am J Paffiol 1988; 132:479-488.
9. Gotlieb A. I., Langille B. L, M. K. Wong., Kim D. W. Biology of disease: structure and function of the endothelial cytoskeleton. Lab Invest 1991; 65: 123-127.
10. Hinshaw D. B., Burger J. M., Armstrong B. C., Hyslop P. A. Mechanism of endothelial cell shape change in oxidant injury. J Surg Res 1989; 46:339-349.
11. Horton A. A., Fairhurst S. Lipid peroxidation and mechanisms of toxicity. CRC Crit Rev Toxicol 1987; 18:27-79.
12. Karman R. J., Garcia J. G. N., Hart C. M. Oleic acid attenuates endothelial cell monolayer dysfunction caused by oxidized low density lipoprotein. Prostaglandins Leukot Essent Fatty Acids (in press).
13. Boissonneault G. A., Wang Y., Chung B. H. Oxidized low-density lipoproteins delay endothelial wound healing: lack of effect of vitamin E. Ann Nutr Metab 1995; 39: 1-8.
14. Boissonneault G. A., Hennig B., Wang Y., Wood C. L Aging and endothelial barrier function in culture: effects of chronic exposure to fatty acid hydroperoxides and vitamin E. Mech Age Devel 1990; 56: 1-9.
15. 2-isoprostanes during the oxidative modification of low-density lipoprotein. Biochem Biophys Res Commun 1994; 200: 338-348.
16. 2-isoprostanes during aortic endothelial cell-mediated oxidation of low-density lipoprotein. FEBS Lett 1994; 348: 297-300.
17. 2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93: 998-1004.
18. Serhan C., Anderson P., Goodman E., Dunham P., Weisman G. Phosphatidate and oxidized fatty acids are calcium ionophores. J Biol Chem 1981; 256: 2736-2741.
19. Esterbauer H., Schaub R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
20. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-9387.
21. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest 1992; 90: 2502-2507.
22. 2α, in rabbit lung in situ. Am J Physiol 1992; 263: H660-H663.
23. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993; 264:01619-1624.
24. 2α, in the rat. J Clin Invest 1992; 90: 136-141.
25. Hart C. M., Tolson J. K., Block E. R. Fatty acid supplementation protects pulmonary artery endothelial cells from oxidant injury. Am J Respir Cell Mol Biol 1990; 3: 479-489.
26. Block E. R., Patel J., Sheridan N. P. Effect of oxygen and endotoxin on lactate dehydrogenase release, 5-hydroxytryptamine uptake, and antioxidant enzyme activities in endothelial cells. J Cell Physiol 1985; 122: 240-248.
27. 2-isoprostanes produced by non-cyclooxygenase free radicalcatalyzed mechanism. Meth Enzymol 1994; 233: 163-173.
28. Folch J., Lees M., Sloane-Stanley G. H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
29. Beuge J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol 1978; LII: 302-310.
30. Bradford M. M. A rapid sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Annal Biochem 1976; 72: 248-254.
31. Dito W. Lactate dehydrogenase: a brief review. In: Griffith J, ed. Clinical Enzymology. New York: Masson Press, 1979: 1-16.
32. Morrow J. D., Awad J. A., Boss H. J., Blair I. A., Roberts L. J. II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 1992; 89:10721-10725.
33. Smith C. V., Anderson R. E. Methods for determination of lipid peroxidation in biological samples. Free Rad Biol Med 1987; 3: 341-344.
34. Halliwell B., Gutteridge J. M. C. Free Radicals in Biology and Medicine. 2nd ed. Oxford: Clarendon Press, 1989: 218-234.
35. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203.
36. Morrow J. D., Roberts L J. II. Quantification of noncyclooxygenase-derived prostanoids as a marker of oxidative stress. Free Rad Biol Med 1991; 10:195-200.
37. Reilly M., Delanty N., Lawson J. A., FitzGerald G. A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25.
38. 2α, in the airways of human subjects. Am J Respir Cell Mol Biol 1993; 9: 568-572.
39. 2/prostaglandin endoperoxide receptors in porcine carotid arteries. Biochem Biophys Res Commun 1996; 225: 915-923.
40. 2α in isolated perfused rat lung. J Appl Physiol 1993; 74: 460-465.
41. 2-isoprostanes. J Nutr 1994; 124: 810-816.
42. Territo M., Berliner J., Fogelman A. Effect of monocyte migration on low density lipoprotein transport across aortic endothelial cell monolayers. J Clin Invest 1984; 74: 2279-2284.